The Breast Cancer GeCIP Domain will use the 100,000 Genomes Project to better understand how changes (mutations) in someone’s DNA may have caused a tumour to form. They are also interested in how DNA changes might change someone’s risk of developing cancer. The group will also investigate how mutations in the tumour itself can influence how it develops and reacts to treatment. They hope to identify patients where alternative treatments can be repurposed and made more effective.
Dr Nicholas Turner
Institute of Cancer Research